Immunity
Volume 38, Issue 2, 21 February 2013, Pages 296-308
Journal home page for Immunity

Article
Angiotensin II Drives the Production of Tumor-Promoting Macrophages

https://doi.org/10.1016/j.immuni.2012.10.015Get rights and content
Under an Elsevier user license
open archive

Summary

Macrophages frequently infiltrate tumors and can enhance cancer growth, yet the origins of the macrophage response are not well understood. Here we address molecular mechanisms of macrophage production in a conditional mouse model of lung adenocarcinoma. We report that overproduction of the peptide hormone Angiotensin II (AngII) in tumor-bearing mice amplifies self-renewing hematopoietic stem cells (HSCs) and macrophage progenitors. The process occurred in the spleen but not the bone marrow, and was independent of hemodynamic changes. The effects of AngII required direct hormone ligation on HSCs, depended on S1P1 signaling, and allowed the extramedullary tissue to supply new tumor-associated macrophages throughout cancer progression. Conversely, blocking AngII production prevented cancer-induced HSC and macrophage progenitor amplification and thus restrained the macrophage response at its source. These findings indicate that AngII acts upstream of a potent macrophage amplification program and that tumors can remotely exploit the hormone’s pathway to stimulate cancer-promoting immunity.

Highlights

▸ AngII-AGTR1A signaling promotes splenic amplification of macrophage progenitors ▸ AngII retains HSCs and macrophage progenitors in spleen by repressing S1P1 sensing ▸ Mouse NSCLC exploits the AngII pathway to amplify the macrophage response ▸ Controlling AngII production restrains tumor-promoting macrophage response in mice

Cited by (0)

5

These authors contributed equally to this work